To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CHCHD3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
365 supporting clones for gene CHCHD3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AA206079   .a 1 to 362 1 to 358   tiling clone, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 358/363
(98 %)
9 diff
(97.6 %id)
D56075   .a 153 to 365 1 to 212       212/212
(100 %)
1 diff
(99.6 %id)
AK310236 testis .a 154 to 1463 1 to 1310 exact tiling clone,   1310/1310
(100 %)
0 diff
(100 %id)
DB025781 testis .a 155 to 706 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
Z43982 brain, total brain .a 161 to 462 1 to 300       300/300
(100 %)
3 diff
(99.0 %id)
AA205972   .a 1584 to 2119 543 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 526/526
(100 %)
15 diff
(97.2 %id)
Z40040 brain, total brain .a 1765 to 2119 355 to 1       355/355
(100 %)
1 diff
(99.8 %id)
CR592685 neuroblastoma .b 1 to 1570 1 to 1570 exact tiling clone,   1570/1570
(100 %)
0 diff
(100 %id)
BE267471 lung, small cell carcinoma .c 1 to 564 20 to 583   tiling clone,   564/988
(57 %)
13 diff
(98.7 %id)
TI_57244696   .c 20 to 800 28 to 809       782/810
(96 %)
10 diff
(98.8 %id)
BI917406 brain .c 25 to 800 1 to 777       777/778
(99 %)
5 diff
(99.4 %id)
BP361375 thalamus .c 31 to 612 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA605967   .c 34 to 564 2 to 533   capped   532/556
(95 %)
7 diff
(98.8 %id)
BY796188 eye .c 35 to 630 1 to 596       596/596
(100 %)
0 diff
(100 %id)
BQ637857 eye, retina .c 36 to 639 1 to 604       604/618
(97 %)
0 diff
(100 %id)
BF971358 adrenal cortex carcinoma, cell line, adrenal gland .c 37 to 807 1 to 763       763/768
(99 %)
14 diff
(98.2 %id)
BP362092 thalamus .c 37 to 616 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
DA007294   .c 40 to 606 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA618999   .c 40 to 629 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
BM466845 eye, retinoblastoma .c 53 to 784 1 to 733       733/1094
(67 %)
11 diff
(99.0 %id)
BM799791 eye, retinoblastoma .c 54 to 1033 1 to 1001 K170X N221H E229* tiling clone,   1001/1128
(88 %)
33 diff
(97.1 %id)
AL516679 brain, neuroblastoma, neuroblastoma cells .c 55 to 877 1 to 824 exact tiling clone, fully sequenced,   824/824
(100 %)
1 diff
(99.9 %id)
BE260215 brain, neuroblastoma .c 55 to 639 1 to 586       586/705
(83 %)
4 diff
(99.5 %id)
BM480102 eye, retinoblastoma .c 55 to 1000 1 to 947 K208X K224N Q225R S226A M227C ... tiling clone,   947/1088
(87 %)
23 diff
(97.9 %id)
DA618190   .c 58 to 564 2 to 510   capped   509/532
(95 %)
9 diff
(98.4 %id)
DA366418 subthalamic nucleus .c 59 to 616 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BM475999 eye, retinoblastoma .c 61 to 564 1 to 505       505/1109
(45 %)
7 diff
(99.4 %id)
DA694112   .c 61 to 639 2 to 581   capped   580/583
(99 %)
4 diff
(99.4 %id)
DA057444 cerebellum .c 70 to 637 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA613994   .c 70 to 644 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA695352   .c 70 to 639 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BM462175 eye, retinoblastoma .c 75 to 844 33 to 802       770/1169
(65 %)
14 diff
(98.9 %id)
DA616222   .c 75 to 656 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
BM799466 eye, retinoblastoma .c 77 to 1092 12 to 1045 E229* tiling clone,   1034/1077
(96 %)
41 diff
(96.2 %id)
AW250545 lung, small cell carcinoma .c 80 to 564 9 to 494       486/521
(93 %)
13 diff
(97.6 %id)
DB294337   .c 80 to 827 8 to 755   capped   748/748
(100 %)
1 diff
(99.9 %id)
BE778067 eye, retinoblastoma .c 97 to 846 1 to 755       755/1151
(65 %)
25 diff
(97.9 %id)
AL517606.
matches multiple genes
brain, neuroblastoma, neuroblastoma cells .c 347 to 1059 298 to 1006   tiling clone, also hits gene LOC646572 718/1025
(70 %)
30 diff
(97.1 %id)
BE778436 eye, retinoblastoma .c 347 to 1103 16 to 783       781/855
(91 %)
81 diff
(90.6 %id)
AL516678 brain, neuroblastoma, neuroblastoma cells .c 816 to 1624 809 to 1   tiling clone, fully sequenced,   809/809
(100 %)
20 diff
(97.6 %id)
DB384405   .c 1089 to 1634 545 to 1   tiling clone,   545/555
(98 %)
14 diff
(97.5 %id)
DC385940 skeletal muscle .d 1 to 566 1 to 567   tiling clone,   567/567
(100 %)
1 diff
(99.9 %id)
DC393678 colon, tumor tissue .d 35 to 622 1 to 588       588/588
(100 %)
0 diff
(100 %id)
AL702689 human skeletal muscle .d 38 to 544 1 to 507       507/507
(100 %)
1 diff
(99.9 %id)
AL709379 human skeletal muscle .d 41 to 674 1 to 637       637/657
(96 %)
4 diff
(99.4 %id)
AL702446 human skeletal muscle .d 42 to 542 1 to 501       501/501
(100 %)
0 diff
(100 %id)
DC345268 colon .d 52 to 565 1 to 514       514/514
(100 %)
1 diff
(99.9 %id)
BP341757 stomach mucosa .d 52 to 633 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA432412 colon .d 53 to 633 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
AL702411 human skeletal muscle .d 54 to 583 1 to 529       529/529
(100 %)
5 diff
(99.1 %id)
BM543842 ovary (pool of 3) .d 55 to 888 1 to 848       848/1079
(78 %)
29 diff
(97.4 %id)
TI_57164309   .d 55 to 876 59 to 879       821/879
(93 %)
15 diff
(98.3 %id)
BM561967 leukocyte .d 58 to 1068 10 to 1022 C193W     1013/1113
(91 %)
31 diff
(97.3 %id)
TI_57192946   .d 58 to 848 51 to 842       792/793
(99 %)
8 diff
(99.0 %id)
BQ072764 leukocyte .d 59 to 880 1 to 825       825/1054
(78 %)
9 diff
(99.2 %id)
BI833985 pooled pancreas and spleen .d 60 to 876 1 to 816       816/816
(100 %)
10 diff
(98.8 %id)
BI862056 breast, mammary adenocarcinoma, cell line .d 60 to 848 1 to 790       790/791
(99 %)
8 diff
(99.0 %id)
CR595326 Placenta Cot 25-normalized .d 61 to 1642 1 to 1582 exact     1582/1582
(100 %)
0 diff
(100 %id)
AL549284 placenta, Placenta Cot 25-normalized .d 61 to 829 1 to 770   fully sequenced,   770/770
(100 %)
1 diff
(99.9 %id)
BG826539 muscle, rhabdomyosarcoma .d 65 to 671 1 to 607       607/608
(99 %)
1 diff
(99.9 %id)
BG826486 muscle, rhabdomyosarcoma .d 65 to 874 1 to 809       809/809
(100 %)
3 diff
(99.7 %id)
BG717531 testis .d 67 to 931 1 to 862 A167V E168K E169R V170W E171K ...     862/912
(94 %)
27 diff
(97.1 %id)
DC344674 colon .d 68 to 558 1 to 491       491/491
(100 %)
2 diff
(99.6 %id)
AL702727 human skeletal muscle .d 68 to 353 1 to 286       286/286
(100 %)
1 diff
(99.7 %id)
DC329340 corpus callosum .d 69 to 610 1 to 542       542/542
(100 %)
1 diff
(99.9 %id)
DC356452 heart .d 69 to 595 1 to 528       528/552
(95 %)
5 diff
(99.1 %id)
BQ441419 bone marrow, from acute myelogenous leukemia .d 69 to 844 1 to 781       781/789
(98 %)
10 diff
(98.8 %id)
BP275535 Kidney .d 69 to 646 1 to 578       578/578
(100 %)
3 diff
(99.5 %id)
DC428256   .d 69 to 558 1 to 490       490/490
(100 %)
0 diff
(100 %id)
CN427318 embryonic stem cells, cell lines H1, H7, andH9 .d 70 to 621 1 to 552       552/552
(100 %)
0 diff
(100 %id)
DA897166 skeletal muscle .d 70 to 631 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DC386604   .d 71 to 625 1 to 556       556/556
(100 %)
2 diff
(99.7 %id)
CX785975 human embryonic stem cells .d 72 to 881 1 to 810       810/820
(98 %)
0 diff
(100 %id)
BP291039 lung .d 72 to 380 1 to 309       309/581
(53 %)
4 diff
(99.4 %id)
BM825907 Ascites, stomach .d 72 to 330 1 to 259       259/259
(100 %)
1 diff
(99.7 %id)
DB008542 cervix, tumor tissue .d 72 to 647 2 to 577   capped   576/577
(99 %)
1 diff
(99.9 %id)
BX387595 Placenta Cot 25-normalized .d 75 to 995 1 to 915 exact     915/984
(92 %)
10 diff
(99.0 %id)
BE276001 melanotic melanoma, skin .d 75 to 737 25 to 685       661/685
(96 %)
8 diff
(98.9 %id)
TI_57178978   .d 75 to 857 27 to 813       787/813
(96 %)
9 diff
(98.9 %id)
BI765924 pooled colon, kidney, stomach .d 76 to 900 1 to 824       824/824
(100 %)
15 diff
(98.2 %id)
BM564528 duodenal adenocarcinoma, cell line, small intestine .d 76 to 674 1 to 599       599/895
(66 %)
3 diff
(99.7 %id)
CV813830 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 76 to 870 1 to 799       799/902
(88 %)
9 diff
(99.1 %id)
TI_57149698   .d 76 to 900 1 to 824       824/824
(100 %)
15 diff
(98.2 %id)
BC014839 Cervix, carcinoma .d 77 to 1669 1 to 1593 exact available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1593/1593
(100 %)
0 diff
(100 %id)
BF794650 lymph, lymphoma, cell line .d 77 to 699 1 to 623       623/623
(100 %)
0 diff
(100 %id)
CR606831 Placenta Cot 25-normalized .d 78 to 1642 1 to 1565 exact     1565/1565
(100 %)
0 diff
(100 %id)
AL552831 placenta, Placenta Cot 25-normalized .d 78 to 829 1 to 751   fully sequenced,   751/751
(100 %)
2 diff
(99.8 %id)
BM083378 melanotic melanoma, skin .d 78 to 746 1 to 669       669/705
(94 %)
2 diff
(99.8 %id)
BC011596 Skin, melanotic melanoma. .d 79 to 1669 1 to 1591 exact available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1591/1591
(100 %)
1 diff
(100.0 %id)
BG746875 adenocarcinoma cell line, colon .d 79 to 595 1 to 520       520/916
(56 %)
9 diff
(99.1 %id)
TI_57176954   .d 79 to 589 53 to 563       511/933
(54 %)
7 diff
(99.3 %id)
AW651701 cervical carcinoma cell line, cervix .d 80 to 516 1 to 437       437/437
(100 %)
0 diff
(100 %id)
BM846708 myeloma .d 80 to 504 1 to 425       425/425
(100 %)
0 diff
(100 %id)
DA038904   .d 81 to 646 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA366990 subthalamic nucleus .d 81 to 590 2 to 511   capped   510/510
(100 %)
1 diff
(99.9 %id)
BE742627 adenocarcinoma cell line, ovary .d 82 to 590 1 to 510       510/510
(100 %)
1 diff
(99.9 %id)
BM916407 amelanotic melanoma, cell line, skin .d 83 to 471 32 to 419       388/1133
(34 %)
22 diff
(98.1 %id)
BP321470 placenta .d 83 to 663 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BM559626 amelanotic melanoma, cell line, skin .d 84 to 1069 1 to 997 E196G N197E T198H H199P Q200P ...     997/1085
(91 %)
32 diff
(97.1 %id)
CX756709 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 84 to 796 1 to 713     Submitted on the opposite strand 713/713
(100 %)
2 diff
(99.8 %id)
AK000427   .d 85 to 1679 1 to 1595 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1595/1595
(100 %)
3 diff
(99.9 %id)
BP281733 bone marrow .d 86 to 667 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
NM_017812.2   .d 86 to 1679 1 to 1594 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1594/1594
(100 %)
2 diff
(99.9 %id)
DA612477   .d 87 to 662 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BP210404 cerebellum .d 89 to 670 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP245103 Kidney .d 89 to 668 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
CB116409 Liver .d 89 to 529 1 to 441       441/441
(100 %)
0 diff
(100 %id)
DA700559   .d 89 to 558 2 to 472   capped   471/471
(100 %)
2 diff
(99.6 %id)
DA005375   .d 90 to 659 2 to 572   capped   571/572
(99 %)
2 diff
(99.7 %id)
CB136478 Liver .d 90 to 575 1 to 486       486/486
(100 %)
0 diff
(100 %id)
DA895945 skeletal muscle .d 90 to 652 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB193546 ovary, tumor tissue .d 90 to 661 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
CR601305 B cells (Ramos cell line) .d 91 to 1673 1 to 1583 exact     1583/1583
(100 %)
0 diff
(100 %id)
BX382230 Placenta Cot 25-normalized .d 91 to 1073 1 to 978 exact     978/978
(100 %)
14 diff
(98.6 %id)
TI_57216042   .d 91 to 954 19 to 890 I190D L191S Q192S C193G Y194V ...     872/890
(97 %)
17 diff
(98.1 %id)
BQ935030 large cell carcinoma, lung .d 94 to 1025 1 to 936 Q187X E224*     936/937
(99 %)
15 diff
(98.4 %id)
TI_57188977   .d 95 to 848 48 to 801       754/754
(100 %)
3 diff
(99.7 %id)
BX362564   .d 96 to 998 1 to 902 G2V T201X S205X L207X A208X ...     902/902
(100 %)
18 diff
(98.1 %id)
BI766464 pooled lung and spleen .d 96 to 881 1 to 786       786/800
(98 %)
5 diff
(99.4 %id)
BI859643 breast, mammary adenocarcinoma, cell line .d 96 to 848 1 to 753       753/753
(100 %)
3 diff
(99.7 %id)
TI_57177628   .d 96 to 895 30 to 829       800/829
(96 %)
10 diff
(98.8 %id)
BX404016 neuroblastoma .d 97 to 1119 6 to 1020 S179X H217X Q220X     1015/1117
(90 %)
17 diff
(98.5 %id)
BX464871 neuroblastoma .d 97 to 925 6 to 834 N197K T198H     829/851
(97 %)
10 diff
(98.9 %id)
DN990272 brain, whole brain .d 98 to 595 1 to 499       499/690
(72 %)
8 diff
(98.9 %id)
BX381047 Placenta Cot 25-normalized .d 99 to 1049 1 to 937 exact     937/1029
(91 %)
14 diff
(98.7 %id)
BE385313 melanotic melanoma, skin .d 99 to 587 1 to 488       488/488
(100 %)
1 diff
(99.8 %id)
BF026913 melanotic melanoma, skin .d 99 to 931 1 to 827 F174V K175Q R176A Y177I E178*     827/827
(100 %)
16 diff
(98.1 %id)
BF026768 melanotic melanoma, skin .d 99 to 815 1 to 718       718/718
(100 %)
2 diff
(99.8 %id)
BI753638 brain .d 99 to 954 1 to 864 I190D L191S Q192S C193G Y194V ...     864/864
(100 %)
11 diff
(98.8 %id)
BQ441136 leiomyosarcoma, uterus .d 102 to 853 1 to 760       760/909
(83 %)
19 diff
(98.0 %id)
CX758767 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 102 to 877 1 to 773     Submitted on the opposite strand 773/787
(98 %)
3 diff
(99.7 %id)
CN427321 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 103 to 816 1 to 715       715/715
(100 %)
2 diff
(99.8 %id)
BE746349 adenocarcinoma cell line, ovary .d 103 to 877 1 to 775       775/794
(97 %)
11 diff
(98.7 %id)
BM452118 melanotic melanoma, skin .d 103 to 965 1 to 865 H199T Q200R T201P L202S K203N ...     865/1125
(76 %)
6 diff
(99.5 %id)
CR979540 T-Lymphocytes .d 103 to 852 1 to 750       750/750
(100 %)
0 diff
(100 %id)
CN427322 embryonic stem cells, cell lines H1, H7, andH9 .d 104 to 788 1 to 685       685/685
(100 %)
0 diff
(100 %id)
DA320557 hippocampus .d 105 to 391 2 to 288   capped   287/557
(51 %)
1 diff
(99.9 %id)
DA321050.
matches multiple genes
hippocampus .d 105 to 391 2 to 289   capped also hits gene EXOC4 288/465
(61 %)
2 diff
(99.6 %id)
BF982246 duodenal adenocarcinoma, cell line, small intestine .d 105 to 848 1 to 745       745/746
(99 %)
11 diff
(98.6 %id)
BG388784 embryonal carcinoma, cell line, testis .d 105 to 815 1 to 709       709/709
(100 %)
4 diff
(99.5 %id)
BG820715 anaplastic oligodendroglioma with 1p/19qloss, brain .d 105 to 674 1 to 573       573/581
(98 %)
3 diff
(99.5 %id)
BM792037 Ascites, stomach .d 105 to 347 1 to 243       243/243
(100 %)
12 diff
(95.1 %id)
BG389575 embryonal carcinoma, cell line, testis .d 106 to 863 1 to 753       753/779
(96 %)
10 diff
(98.8 %id)
BQ426080 melanotic melanoma, skin .d 106 to 881 1 to 786       786/928
(84 %)
12 diff
(98.8 %id)
BP222427   .d 107 to 687 1 to 582       582/582
(100 %)
8 diff
(98.7 %id)
BQ221031 embryonal carcinoma, cell line, testis .d 107 to 881 1 to 773       773/890
(86 %)
10 diff
(98.9 %id)
BP273482   .d 107 to 690 1 to 584       584/584
(100 %)
4 diff
(99.4 %id)
DA910800   .d 108 to 656 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BE275134 melanotic melanoma, skin .d 109 to 886 8 to 786       779/951
(81 %)
15 diff
(98.5 %id)
BQ691855 ductal carcinoma, cell line, Pancreas .d 109 to 988 1 to 882 E224G K225E G227R     882/882
(100 %)
9 diff
(99.0 %id)
CR590478 Placenta Cot 25-normalized .d 111 to 1637 1 to 1527 exact     1527/1527
(100 %)
0 diff
(100 %id)
BX396252 Placenta Cot 25-normalized .d 111 to 776 1 to 666   fully sequenced,   666/666
(100 %)
1 diff
(99.9 %id)
DA899382 skeletal muscle .d 111 to 667 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
CN427319 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 112 to 805 1 to 693       693/693
(100 %)
1 diff
(99.9 %id)
BX360126 Placenta Cot 25-normalized .d 112 to 1054 1 to 935 exact     935/935
(100 %)
13 diff
(98.7 %id)
BE889105 leiomyosarcoma, uterus .d 112 to 860 1 to 750       750/752
(99 %)
7 diff
(99.1 %id)
BM547080 brain, hippocampus .d 112 to 1142 21 to 1061 exact     1041/1063
(97 %)
36 diff
(96.7 %id)
CR619969 neuroblastoma .d 114 to 1672 1 to 1559 exact     1559/1559
(100 %)
0 diff
(100 %id)
BQ227988 leiomyosarcoma, uterus .d 115 to 1002 12 to 904 exact     893/948
(94 %)
16 diff
(98.4 %id)
BE261384 brain, neuroblastoma .d 116 to 624 1 to 507       507/508
(99 %)
3 diff
(99.5 %id)
BI223818 cervical carcinoma cell line, cervix .d 117 to 731 1 to 615       615/615
(100 %)
0 diff
(100 %id)
BM804503 lymph, lymphoma, cell line .d 119 to 1026 13 to 931 K135X H180Q P181S V182S C183L ...     919/1152
(79 %)
42 diff
(96.4 %id)
DA897429 skeletal muscle .d 120 to 667 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
BE891879 melanotic melanoma, skin .d 121 to 744 1 to 627       627/935
(67 %)
5 diff
(99.5 %id)
BI858573 breast, mammary adenocarcinoma, cell line .d 121 to 983 1 to 864 G227R     864/865
(99 %)
7 diff
(99.2 %id)
TI_57191495   .d 121 to 983 87 to 950 G227R     864/865
(99 %)
7 diff
(99.2 %id)
BE267484 lung, small cell carcinoma .d 122 to 470 24 to 372       349/563
(61 %)
8 diff
(98.6 %id)
BG261410 bladder, transitional cell papilloma, cell line .d 124 to 595 1 to 472       472/856
(55 %)
3 diff
(99.7 %id)
AA306737   .d 125 to 546 1 to 422       422/422
(100 %)
0 diff
(100 %id)
BQ892058 brain, neuroblastoma, cell line .d 125 to 1059 1 to 940 S42F E196X N197E T198H H199P ...     940/942
(99 %)
22 diff
(97.7 %id)
CV810976 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 125 to 881 1 to 757       757/778
(97 %)
6 diff
(99.3 %id)
BP355901   .d 125 to 699 8 to 582       575/582
(98 %)
7 diff
(98.8 %id)
AA306517   .d 127 to 465 1 to 339       339/340
(99 %)
1 diff
(99.8 %id)
CX754248 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 127 to 818 42 to 732     Submitted on the opposite strand 691/733
(94 %)
12 diff
(98.4 %id)
CN427316 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 131 to 873 16 to 757       742/757
(98 %)
6 diff
(99.3 %id)
CN427317 embryonic stem cells, cell lines H1, H7, andH9 .d 133 to 881 1 to 748       748/760
(98 %)
3 diff
(99.7 %id)
BF229889 colon_est .d 137 to 586 452 to 2       451/457
(98 %)
3 diff
(99.4 %id)
BQ231086 large cell carcinoma, lung .d 148 to 965 1 to 825 K165X A206R L207S A208G T209H ...     825/1070
(77 %)
13 diff
(98.8 %id)
BE535427 cervix .d 150 to 881 1 to 731       731/853
(85 %)
16 diff
(98.2 %id)
DB462214 testis .d 203 to 681 1 to 479       479/479
(100 %)
0 diff
(100 %id)
TI_1948100875   .d 212 to 503 119 to 410   fully sequenced,   292/310
(94 %)
5 diff
(98.4 %id)
TI_1948100537   .d 221 to 535 124 to 438       315/341
(92 %)
6 diff
(98.3 %id)
TI_1948100711   .d 221 to 527 126 to 432       307/333
(92 %)
6 diff
(98.2 %id)
CV024886 mixed .d 222 to 865 1 to 639       639/639
(100 %)
5 diff
(99.3 %id)
TI_1948100383   .d 223 to 526 129 to 432       304/332
(91 %)
6 diff
(98.2 %id)
BQ897805 epidermoid carcinoma, cell line, salivary gland .d 233 to 1042 1 to 825       825/918
(89 %)
29 diff
(96.9 %id)
DR155443 human embryonic stem cells differentiated toan early endodermal cell type .d 274 to 1098 1 to 825       825/825
(100 %)
0 diff
(100 %id)
BI054268 placenta_normal .d 339 to 806 470 to 4       467/470
(99 %)
2 diff
(99.6 %id)
BI054266 placenta_normal .d 365 to 809 465 to 20       446/465
(95 %)
2 diff
(99.6 %id)
BE696046 colon .d 387 to 556 179 to 11       169/179
(94 %)
0 diff
(100 %id)
BM556749 duodenal adenocarcinoma, cell line, small intestine .d 389 to 1322 8 to 950       943/1003
(94 %)
23 diff
(97.8 %id)
CB123867 Liver .d 392 to 898 9 to 515       507/515
(98 %)
0 diff
(100 %id)
BM817518 Ascites, stomach .d 429 to 711 1 to 283       283/283
(100 %)
0 diff
(100 %id)
CN427320 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 432 to 1122 2 to 692       691/692
(99 %)
6 diff
(99.2 %id)
TI_1948100876   .d 442 to 881 592 to 153   fully sequenced,   440/592
(74 %)
0 diff
(100 %id)
CB118875 Liver .d 489 to 1018 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
BQ050533 leiomyosarcoma, uterus .d 493 to 1309 1 to 835       835/1083
(77 %)
23 diff
(97.9 %id)
BU662163 blood .d 564 to 1131 1 to 567       567/567
(100 %)
7 diff
(98.8 %id)
R86167 liver and spleen .d 570 to 1018 1 to 451       451/456
(98 %)
9 diff
(98.1 %id)
BG182544   .d 586 to 1379 1 to 794       794/794
(100 %)
10 diff
(98.8 %id)
BG220497   .d 586 to 1347 1 to 761       761/762
(99 %)
21 diff
(97.3 %id)
BE162522 head_neck .d 590 to 927 29 to 366       338/367
(92 %)
8 diff
(97.9 %id)
BF988684 placenta_normal .d 590 to 962 397 to 25       373/408
(91 %)
0 diff
(100 %id)
BX100859 liver and spleen .d 590 to 1372 10 to 792       783/792
(98 %)
7 diff
(99.2 %id)
R02239 liver and spleen .d 590 to 888 9 to 313       305/351
(86 %)
19 diff
(94.6 %id)
BF308534 muscle, rhabdomyosarcoma .d 590 to 1263 65 to 734       670/825
(81 %)
13 diff
(98.5 %id)
BG179502 adenocarcinoma, cell line, Prostate .d 590 to 1198 40 to 684       642/918
(69 %)
63 diff
(93.2 %id)
BQ890228 brain, neuroblastoma, cell line .d 591 to 1312 43 to 775       733/927
(79 %)
27 diff
(97.1 %id)
BG184113   .d 592 to 1318 1 to 717       717/845
(84 %)
15 diff
(98.3 %id)
BG186235   .d 592 to 946 1 to 355       355/355
(100 %)
0 diff
(100 %id)
BG193548   .d 592 to 846 1 to 255       255/255
(100 %)
0 diff
(100 %id)
BG219998   .d 592 to 755 1 to 164       164/164
(100 %)
0 diff
(100 %id)
TI_1948100384   .d 593 to 881 440 to 152       289/339
(85 %)
0 diff
(100 %id)
BM794131 Ascites, stomach .d 599 to 1155 1 to 557       557/557
(100 %)
0 diff
(100 %id)
TI_1948100538   .d 599 to 881 435 to 153       283/333
(84 %)
0 diff
(100 %id)
TI_1948100712   .d 606 to 881 424 to 149       276/326
(84 %)
0 diff
(100 %id)
BF969250 adrenal cortex carcinoma, cell line, adrenal gland .d 619 to 1362 1 to 743       743/757
(98 %)
4 diff
(99.5 %id)
BG983385 colon_normal .d 639 to 968 330 to 1       330/330
(100 %)
2 diff
(99.4 %id)
CN427323 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 642 to 1220 15 to 593       579/593
(97 %)
0 diff
(100 %id)
H44264 breast .d 648 to 1053 1 to 415       415/484
(85 %)
17 diff
(96.5 %id)
BG186236   .d 670 to 1515 1 to 844       844/928
(90 %)
61 diff
(93.5 %id)
BG215920   .d 672 to 1277 1 to 613       613/969
(63 %)
26 diff
(97.4 %id)
H22211 breast .d 705 to 950 1 to 246       246/246
(100 %)
10 diff
(96.0 %id)
BU933535 mixed (pool of 40 RNAs) .d 708 to 1309 1 to 607       607/817
(74 %)
8 diff
(99.1 %id)
BX396251 Placenta Cot 25-normalized .d 715 to 1632 921 to 6   fully sequenced,   916/921
(99 %)
1 diff
(99.9 %id)
BG171864 hypernephroma, cell line, Kidney .d 734 to 1440 1 to 706       706/983
(71 %)
12 diff
(98.8 %id)
BG185166   .d 742 to 1529 1 to 785       785/785
(100 %)
15 diff
(98.1 %id)
CR597341 Placenta Cot 25-normalized .d 746 to 1672 1 to 927       927/927
(100 %)
0 diff
(100 %id)
AL551814 placenta, Placenta Cot 25-normalized .d 746 to 1672 1 to 927   fully sequenced,   927/927
(100 %)
0 diff
(100 %id)
AI684632 pooled .d 746 to 1177 449 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 437/437
(100 %)
2 diff
(99.6 %id)
BM853273 myeloma .d 747 to 1304 1 to 558       558/558
(100 %)
0 diff
(100 %id)
BM845315 myeloma .d 747 to 1109 1 to 363       363/363
(100 %)
0 diff
(100 %id)
TI_149311933   .d 752 to 1675 1007 to 93   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 915/980
(93 %)
15 diff
(98.5 %id)
BF089003 head_neck .d 761 to 1063 301 to 1       301/301
(100 %)
2 diff
(99.4 %id)
BG177334 lymph, lymphoma, cell line .d 793 to 1541 1 to 749       749/966
(77 %)
19 diff
(98.1 %id)
BE392268 endometrium, adenocarcinoma cell line, uterus .d 798 to 1446 1 to 639       639/719
(88 %)
15 diff
(98.0 %id)
AL549283 placenta, Placenta Cot 25-normalized .d 799 to 1642 843 to 1   fully sequenced,   843/843
(100 %)
6 diff
(99.3 %id)
AL575996 placenta, Placenta Cot 25-normalized .d 799 to 1642 845 to 1   fully sequenced,   845/845
(100 %)
2 diff
(99.8 %id)
BM015192 breast, mammary adenocarcinoma, cell line .d 806 to 1536 17 to 750       734/750
(97 %)
14 diff
(98.2 %id)
TI_59393316   .d 806 to 1536 96 to 829       734/750
(97 %)
14 diff
(98.2 %id)
BG186237   .d 808 to 1656 862 to 17     Submitted on the opposite strand 846/985
(85 %)
10 diff
(99.0 %id)
BE697673 colon .d 819 to 1348 10 to 534       525/534
(98 %)
11 diff
(98.0 %id)
BE697656 colon .d 828 to 1318 9 to 498       490/498
(98 %)
9 diff
(98.2 %id)
BG167552 hypernephroma, cell line, Kidney .d 835 to 1665 1 to 831       831/1005
(82 %)
27 diff
(97.4 %id)
BE697668 colon .d 836 to 1393 1 to 554       554/554
(100 %)
7 diff
(98.8 %id)
BE697651 colon .d 847 to 1295 1 to 449       449/449
(100 %)
6 diff
(98.7 %id)
BF966063 Bone, osteosarcoma, cell line .d 847 to 1654 1 to 809       809/944
(85 %)
38 diff
(96.0 %id)
BU537557 mixed (pool of 40 RNAs) .d 856 to 1563 1 to 714       714/774
(92 %)
13 diff
(98.4 %id)
BG185167   .d 868 to 1210 21 to 362       342/362
(94 %)
14 diff
(96.2 %id)
BG189378   .d 876 to 1491 1 to 618       618/943
(65 %)
32 diff
(96.7 %id)
BG193549   .d 876 to 1413 1 to 545       545/921
(59 %)
35 diff
(96.2 %id)
BG205332   .d 876 to 1557 1 to 683       683/940
(72 %)
22 diff
(97.7 %id)
BG206406   .d 876 to 1669 1 to 795   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 795/795
(100 %)
11 diff
(98.7 %id)
BG189945   .d 877 to 1619 1 to 741       741/900
(82 %)
28 diff
(96.9 %id)
BG195562   .d 877 to 1087 1 to 213       213/216
(98 %)
10 diff
(95.4 %id)
BG212013   .d 877 to 1425 1 to 549       549/933
(58 %)
24 diff
(97.5 %id)
BG214314   .d 877 to 1618 1 to 730       730/916
(79 %)
53 diff
(94.3 %id)
BG194532   .d 879 to 1088 36 to 249       214/249
(85 %)
6 diff
(97.6 %id)
AL551793 placenta, Placenta Cot 25-normalized .d 879 to 1612 766 to 31   fully sequenced,   736/766
(96 %)
0 diff
(100 %id)
TI_149299880   .d 879 to 1669 884 to 103   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 782/939
(83 %)
12 diff
(98.8 %id)
TI_227714851   .d 879 to 1675 883 to 93   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 791/987
(80 %)
12 diff
(98.8 %id)
BG212687   .d 880 to 1576 1 to 698       698/843
(82 %)
84 diff
(90.1 %id)
AA985419 Kidney, kidney tumor .d 897 to 1136 239 to 1       239/239
(100 %)
1 diff
(99.6 %id)
CB242069 Human Lung Epithelial cells, lung .d 897 to 1673 787 to 15   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 773/777
(99 %)
6 diff
(99.3 %id)
BF793047 adrenal cortex carcinoma, cell line, adrenal gland .d 902 to 1672 1 to 769       769/779
(98 %)
9 diff
(98.9 %id)
BF792980 adrenal cortex carcinoma, cell line, adrenal gland .d 902 to 1669 1 to 756   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 756/756
(100 %)
15 diff
(98.1 %id)
CA426599 cell lines, Chondrosarcoma .d 906 to 1679 783 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 765/769
(99 %)
10 diff
(98.7 %id)
BQ009630 Chondrosarcoma, Left Pubic Bone .d 912 to 1673 775 to 15   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 761/761
(100 %)
2 diff
(99.8 %id)
BU163249 melanotic melanoma, cell line, skin .d 918 to 1673 788 to 31   AAA Submitted on the opposite strand 758/911
(83 %)
14 diff
(98.5 %id)
BM977673 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 919 to 1675 773 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 757/757
(100 %)
1 diff
(99.9 %id)
Z33577   .d 930 to 1157 1 to 228       228/228
(100 %)
2 diff
(99.2 %id)
BQ009165 Chondrosarcoma, Left Pubic Bone .d 930 to 1673 758 to 15   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 744/744
(100 %)
1 diff
(99.9 %id)
BU838882 melanotic melanoma, cell line, skin .d 930 to 1673 776 to 31   AAA Submitted on the opposite strand 746/912
(81 %)
22 diff
(97.6 %id)
CD367999 Alveolar Macrophage, lung .d 939 to 1673 751 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 733/736
(99 %)
2 diff
(99.8 %id)
BM711268.
matches multiple genes
eye, fetal eyes .d 945 to 1462 1 to 518     also hits gene LOC646572 518/518
(100 %)
0 diff
(100 %id)
CD365462 Alveolar Macrophage, lung .d 947 to 1675 745 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 727/727
(100 %)
2 diff
(99.8 %id)
BG191980   .d 951 to 1651 714 to 19     Submitted on the opposite strand 696/838
(83 %)
0 diff
(100 %id)
BG027024 Bone, osteosarcoma, cell line .d 957 to 1673 1 to 714       714/749
(95 %)
17 diff
(97.8 %id)
BU684968 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 964 to 1669 722 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 706/706
(100 %)
0 diff
(100 %id)
BM852478 stomach .d 979 to 1403 1 to 426       426/426
(100 %)
1 diff
(99.8 %id)
CA443157 lung, Metastatic Chondrosarcoma .d 998 to 1669 688 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 672/682
(98 %)
3 diff
(99.6 %id)
CA443292 lung, Metastatic Chondrosarcoma .d 998 to 1669 688 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 672/677
(99 %)
3 diff
(99.6 %id)
BM853046 Ascites, stomach .d 1007 to 1408 1 to 402       402/402
(100 %)
0 diff
(100 %id)
BQ000869 lung, Metastatic Chondrosarcoma .d 1012 to 1673 676 to 15   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 662/674
(98 %)
2 diff
(99.8 %id)
BG108550 Bone, osteosarcoma, cell line .d 1018 to 1668 1 to 655   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 655/655
(100 %)
8 diff
(98.8 %id)
BM669490 eye, fetal eyes .d 1019 to 1674 673 to 18       656/673
(97 %)
0 diff
(100 %id)
BM993282 lung, Metastatic Chondrosarcoma .d 1027 to 1673 661 to 15   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 647/647
(100 %)
0 diff
(100 %id)
BU618385 Cell Line, Chondrosarcoma .d 1037 to 1673 651 to 15   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 637/637
(100 %)
0 diff
(100 %id)
CB528424 Aveolar Macrophage, lung .d 1037 to 1669 651 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 635/635
(100 %)
2 diff
(99.7 %id)
N28560 melanocyte .d 1064 to 1559 1 to 499       499/502
(99 %)
4 diff
(99.3 %id)
N39271 melanocyte .d 1065 to 1362 1 to 298   fully sequenced,   298/298
(100 %)
2 diff
(99.4 %id)
BM824098 Ascites, stomach .d 1073 to 1629 1 to 557       557/557
(100 %)
0 diff
(100 %id)
AI138618 uterus .d 1087 to 1667 581 to 1       581/581
(100 %)
0 diff
(100 %id)
AW978621   .d 1091 to 1667 578 to 2     Submitted on the opposite strand 577/578
(99 %)
0 diff
(100 %id)
BM793700 Ascites, stomach .d 1093 to 1669 1 to 577   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 577/577
(100 %)
1 diff
(99.9 %id)
BU618745 Cell Line, Chondrosarcoma .d 1093 to 1669 593 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 577/577
(100 %)
1 diff
(99.9 %id)
AI301928 2 pooled tumors (clear cell type), Kidney .d 1096 to 1674 585 to 7       579/585
(98 %)
0 diff
(100 %id)
AJ711275 heart .d 1117 to 1552 20 to 455       436/455
(95 %)
6 diff
(98.7 %id)
AW673162 cervical carcinoma cell line, cervix .d 1143 to 1674 532 to 1       532/532
(100 %)
0 diff
(100 %id)
BG117304 adenocarcinoma, cell line, Liver .d 1143 to 1679 1 to 537   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 537/537
(100 %)
0 diff
(100 %id)
AW149756 brain, medulloblastoma .d 1146 to 1675 531 to 1       531/531
(100 %)
2 diff
(99.7 %id)
N72131.
matches multiple genes
melanocyte .d 1155 to 1673 524 to 2     also hits gene LOC646572 523/525
(99 %)
0 diff
(100 %id)
BF061324 pooled .d 1155 to 1672 522 to 6       517/522
(99 %)
0 diff
(100 %id)
TI_151717915   .d 1156 to 1673 636 to 117   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 520/888
(58 %)
16 diff
(98.2 %id)
BU727490 eye, optic nerve .d 1157 to 1673 535 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 517/517
(100 %)
0 diff
(100 %id)
AW572327 cervix .d 1160 to 1671 512 to 1       512/512
(100 %)
0 diff
(100 %id)
AA648779 germinal center B cell .d 1170 to 1672 509 to 7       503/509
(98 %)
0 diff
(100 %id)
BP395604 pancreatic islet .d 1176 to 1672 1 to 497     Submitted on the opposite strand 497/499
(99 %)
1 diff
(99.8 %id)
BE855460 brain, glioblastoma (pooled) .d 1183 to 1669 486 to 1       486/486
(100 %)
3 diff
(99.4 %id)
AI143313 heart .d 1184 to 1668 486 to 2       485/486
(99 %)
0 diff
(100 %id)
DB527651 testis .d 1197 to 1673 1 to 477     Submitted on the opposite strand 477/477
(100 %)
0 diff
(100 %id)
AA975522 carcinoid, lung .d 1198 to 1674 477 to 2       476/477
(99 %)
0 diff
(100 %id)
AA778153 heart .d 1209 to 1673 477 to 14   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 464/464
(100 %)
1 diff
(99.8 %id)
AA722999 heart .d 1223 to 1673 483 to 33   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 451/451
(100 %)
1 diff
(99.8 %id)
AW051329 pooled .d 1230 to 1673 456 to 13   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 444/444
(100 %)
0 diff
(100 %id)
BM989260 Fibrosarcoma .d 1230 to 1673 458 to 15   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 444/444
(100 %)
0 diff
(100 %id)
CA841781 Pancreas, Purified pancreatic islet .d 1231 to 1674 447 to 4       444/447
(99 %)
0 diff
(100 %id)
AW517080 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1237 to 1672 437 to 2       436/437
(99 %)
0 diff
(100 %id)
AI890817 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 1238 to 1670 433 to 1       433/433
(100 %)
2 diff
(99.6 %id)
AI816051 brain, frontal lobe .d 1241 to 1679 453 to 15   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 439/440
(99 %)
2 diff
(99.6 %id)
F34802 pectoral muscle (after mastectomy) .d 1243 to 1580 1 to 336       336/336
(100 %)
7 diff
(98.0 %id)
AA890364 parathyroid gland, parathyroid tumor .d 1253 to 1669 427 to 11   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 417/417
(100 %)
0 diff
(100 %id)
AA676923 liver and spleen .d 1254 to 1669 416 to 1       416/416
(100 %)
0 diff
(100 %id)
BE047470 ovary, serous papillary tumor .d 1259 to 1673 425 to 11   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 415/415
(100 %)
0 diff
(100 %id)
F37048 pectoral muscle (after mastectomy) .d 1264 to 1603 1 to 340       340/340
(100 %)
0 diff
(100 %id)
AW513551 colon, juvenile granulosa tumor .d 1265 to 1672 410 to 3       408/410
(99 %)
0 diff
(100 %id)
AJ707354 heart .d 1267 to 1667 432 to 32     Submitted on the opposite strand 401/432
(92 %)
0 diff
(100 %id)
AI027574 brain, glioblastoma (pooled) .d 1268 to 1670 403 to 1       403/403
(100 %)
0 diff
(100 %id)
BF432528 brain, glioblastoma (pooled) .d 1268 to 1669 402 to 1       402/402
(100 %)
0 diff
(100 %id)
AI188488 placenta .d 1270 to 1673 417 to 14   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 404/404
(100 %)
1 diff
(99.8 %id)
AW005047 anaplastic oligodendroglioma, brain .d 1270 to 1669 400 to 1       400/400
(100 %)
0 diff
(100 %id)
AA478387 ovarian tumor, ovary .d 1272 to 1673 401 to 1       401/401
(100 %)
1 diff
(99.8 %id)
AA612824 colon, colon tumor RER+ .d 1284 to 1671 388 to 1       388/388
(100 %)
0 diff
(100 %id)
AW628489 2 pooled high-grade transitional celltumors, genitourinary tract .d 1285 to 1673 389 to 1       389/389
(100 %)
0 diff
(100 %id)
AA621905 colon, colon tumor RER+ .d 1293 to 1497 205 to 1       205/205
(100 %)
0 diff
(100 %id)
H44593 breast .d 1312 to 1666 368 to 11       358/373
(95 %)
0 diff
(100 %id)
W61269 heart .d 1312 to 1658 1 to 350   fully sequenced,   350/350
(100 %)
5 diff
(98.6 %id)
N25924 melanocyte .d 1332 to 1677 360 to 1   fully sequenced,   360/360
(100 %)
7 diff
(98.1 %id)
R02125 liver and spleen .d 1336 to 1661 326 to 1       326/326
(100 %)
0 diff
(100 %id)
AA857185 adenocarcinoma, colon .d 1339 to 1669 355 to 25   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 331/331
(100 %)
0 diff
(100 %id)
BF594645 brain, glioblastoma (pooled) .d 1352 to 1664 313 to 1       313/313
(100 %)
0 diff
(100 %id)
AA953161 carcinoid, lung .d 1367 to 1673 307 to 1       307/307
(100 %)
0 diff
(100 %id)
H22159 breast .d 1379 to 1664 286 to 1       286/286
(100 %)
2 diff
(99.4 %id)
AA879072 2 pooled tumors (clear cell type), Kidney .d 1395 to 1669 285 to 11   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 275/275
(100 %)
0 diff
(100 %id)
T16615   .d 1429 to 1673 245 to 1       245/245
(100 %)
0 diff
(100 %id)
W61270 heart .d 1483 to 1670 189 to 1   fully sequenced,   189/189
(100 %)
1 diff
(99.5 %id)
AA758459 liver and spleen .d 1510 to 1669 160 to 1       160/160
(100 %)
0 diff
(100 %id)
AI591034 ovary, tumor, 5 pooled (see description) .d 1565 to 1674 117 to 8       110/117
(94 %)
0 diff
(100 %id)
AI350448   .d 1593 to 1669 88 to 12   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 77/77
(100 %)
0 diff
(100 %id)
BI488641 brain .e 1 to 891 1 to 887 R162Q V163S T164H T165H E166* tiling clone,   887/905
(98 %)
21 diff
(97.7 %id)
TI_45379264   .e 1 to 891 35 to 921 R162Q V163S T164H T165H E166*     887/939
(94 %)
27 diff
(97.2 %id)
CR603574 neuroblastoma .f 1 to 1462 1 to 1462 exact tiling clone,   1462/1462
(100 %)
0 diff
(100 %id)
BM906337 ovary (pool of 3) .g 1 to 846 6 to 864 K24E     859/1119
(76 %)
26 diff
(97.7 %id)
BM847396 myeloma .g 4 to 540 1 to 537   tiling clone,   537/537
(100 %)
2 diff
(99.7 %id)
BG425750 Kidney .g 13 to 800 1 to 791 A138V     791/853
(92 %)
12 diff
(98.6 %id)
AK294071 alzheimer cortex .g 43 to 940 1 to 898 C112R     898/898
(100 %)
2 diff
(99.8 %id)
DC311121 alzheimer cortex .g 43 to 582 1 to 540 C112R     540/540
(100 %)
1 diff
(99.9 %id)
BU860021 adenocarcinoma, cell line, breast .g 222 to 974 21 to 785       765/910
(84 %)
23 diff
(97.5 %id)
BQ220148 melanotic melanoma, skin .g 258 to 1111 1 to 856   tiling clone,   856/857
(99 %)
11 diff
(98.8 %id)
BG429875 Kidney .g 371 to 1045 1 to 675       675/680
(99 %)
10 diff
(98.6 %id)
CR611779 neuroblastoma .g 835 to 1628 1 to 794   tiling clone,   794/794
(100 %)
0 diff
(100 %id)
AL583471 brain, neuroblastoma, neuroblastoma cells .g 835 to 1628 1 to 795   fully sequenced,   795/795
(100 %)
2 diff
(99.8 %id)
AL519230 brain, neuroblastoma, neuroblastoma cells .g 880 to 1612 734 to 1   fully sequenced,   734/734
(100 %)
18 diff
(97.6 %id)
GD143456   .g 1554 to 1624 1 to 71   AAA   71/71
(100 %)
2 diff
(97.2 %id)
CD655284 Embryonic Stem cells .h-u 1 to 772 12 to 778 exact tiling clone,   767/783
(97 %)
20 diff
(97.5 %id)
AL698285 human skeletal muscle .h-u 162 to 698 1 to 537   tiling clone,   537/537
(100 %)
0 diff
(100 %id)
AK025271 colon Gene CHCHD3, variant not shown       available from FLJ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)    
AK129533 pericardium Gene CHCHD3, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
AW899638 nervous_normal Gene CHCHD3, variant not shown              
BE061766 breast Gene CHCHD3, variant not shown         Submitted on the opposite strand    
BG996329 head_neck Gene CHCHD3, variant not shown              
DB301926 amygdala Gene CHCHD3, variant not shown              
DA156253 amygdala Gene CHCHD3, variant not shown       capped      
BX105419 eye, retina Gene CHCHD3, variant not shown              
ES308488 beard hair, skin Gene CHCHD3, variant not shown              
G65571   Gene CHCHD3, variant not shown         Submitted on the opposite strand    
H37915 eye, retina Gene CHCHD3, variant not shown              
H38273 eye, retina Gene CHCHD3, variant not shown              
R84747 eye, retina Gene CHCHD3, variant not shown              
R85746 eye, retina Gene CHCHD3, variant not shown              
AA018876 eye, retina Gene CHCHD3, variant not shown              
AA019023 eye, retina Gene CHCHD3, variant not shown              
AA047225 eye, retina Gene CHCHD3, variant not shown              
BI489517 brain Gene CHCHD3, variant not shown              
BU553869 ovary, teratocarcinoma, cell line Gene CHCHD3, variant not shown              
TI_45379266   Gene CHCHD3, variant not shown              
CB161211 Liver Gene CHCHD3, variant not shown              
DB361265 mammary gland Gene CHCHD3, variant not shown              
DA646570 mammary gland Gene CHCHD3, variant not shown       capped      
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI